We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





Rapid Saliva Tests as Good as PCR Tests for Diagnosing COVID-19 in Early Phase of Infection

By LabMedica International staff writers
Posted on 11 Nov 2021

Researchers investigating whether rapid antigen testing can be used on saliva instead of swabbing the nasal cavity have found that saliva can be good enough for diagnosing COVID-19 in the early phase of infection. More...

The study from Lund University (Lund, Sweden) aimed to find out if rapid COVID-19 tests using saliva could be easier alternatives to the common PCR tests which involve a nose and throat sample taken with a cotton swab - a procedure that is often unpleasant. Quick diagnostic tools are crucial in reducing the spread of COVID-19. Today, there are several different test methods to identify an ongoing infection. The PCR tests used in healthcare and most commercially available antigen tests are usually taken with swabs in the nasal cavity - a method that many find uncomfortable. Antigen tests are used as a complement to PCR testing when increased test capacity or rapid test results are required. However, there are also saliva tests.

In the current study, the researchers compared RT-PCR tests with saliva samples they collected from 44 patients. All 44 participants had confirmed COVID-19, and had to clear their throat before spitting. The results showed that coronavirus can be detected in both saliva and nasal cavity samples, but that the concentrations are slightly lower in saliva. The researchers also examined four different rapid antigen tests available on the market, to see how well they detect the virus in saliva samples. All four antigen tests were found to be relatively sensitive in detecting the virus early in the infection, as the virus concentration is higher at that point. Later in the infection, when the virus concentration is lower, the antigen tests were not sufficiently sensitive. The researchers believe that rapid saliva tests are a good alternative to standard PCR testing, and can also supplement these methods as screening needs increase.

“Although our study isn’t definitive, our results indicate that rapid tests using saliva might be good enough for diagnosing COVID-19 in the early phase of infection”, said Magnus Rasmussen, specialist in infectious disease medicine at Skåne University Hospital and professor at Lund University, who led the study.

“The advantage of a saliva-based rapid test is that you can easily take it at home in peace and quiet. For many, it can make a big difference. If infection occurs in, for example, primary school, the younger unvaccinated students can be screened more quickly with a saliva-based rapid test. For children, it is important that sampling is simple and without discomfort”, added Yang de Marinis, who is the first author of the study.

Related Links:
Lund University 


Gold Member
Multiplex Genetic Analyzer
MassARRAY Dx Analyzer (Europe only)
Serological Pipet Controller
PIPETBOY GENIUS
New
Integrated Biochemical & Immunological System
Biolumi CX8
New
Automatic Hematology Analyzer
LABAS F9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
Image: Pancreatic cancer diagnosis (Photo courtesy of World Journal of Gastroenterology)

AI-Driven Preliminary Testing for Pancreatic Cancer Enhances Prognosis

Pancreatic cancer poses a major global health threat due to its high mortality rate, with 467,409 deaths and 510,992 new cases reported worldwide in 2022. Often referred to as the "king" of all cancers,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.